Andre is CEO of Matchpoint Therapeutics. Prior to joining Atlas, Andre was CEO of Voyager Therapeutics (NASDAQ: VYGR). Andre brings more than 20 years of experience in big pharma and biotech, including senior leadership roles at Genzyme and Sanofi. At Sanofi, he was the Global Head of Business Development & Licensing, where he and his team executed more than 50 deals. Andre earned his BA from Kalamazoo College and his MBA from the Tuck School of Business at Dartmouth.